Home

Lars Boesgaard

CIK 1403893 · Chief Financial Officer · last filed 2026-03-03

Lars Boesgaard is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for PDSB, was dated Mar 3, 2026.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

12

Lifetime Open-Market Net

$0

Filer Profile

Reported Address
C/O ROKA BIOSCIENCE, INC.
20 INDEPENDENCE BOULEVARD
WARREN, NJ 07059
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PDSB Chief Financial Officer — $0.29 — $0 3 2026-03-03
Roka BioScience, Inc. (ROKA) Delisted Vice President, CFO 8,938 — — $0 5 2017-03-28
PODD Vice President of Finance — $131.96 — $0 4 2009-03-02

Recent Filings

12 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-03-03 PDSB Grant (A) — $0 EDGAR
2025-07-25 PDSB Grant (A) — $0 EDGAR
2023-12-04 PDSB Grant (A) — $0 EDGAR
2017-03-28 Roka BioScience, Inc. (ROKA) Delisted Grant (A) — $0 EDGAR
2016-11-10 Roka BioScience, Inc. (ROKA) Delisted Conv (C) +3,572 $25.0K EDGAR
2016-09-23 Roka BioScience, Inc. (ROKA) Delisted Buy (P) — $0 EDGAR
2016-01-05 Roka BioScience, Inc. (ROKA) Delisted Grant (A) — $0 EDGAR
2015-12-07 Roka BioScience, Inc. (ROKA) Delisted Tax (F) −128 -$183 EDGAR
2009-03-02 PODD Grant (A) — $0 EDGAR
2008-03-14 PODD Grant (A) — $0 EDGAR
Showing 1–10 of 12
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.